CM directs thorough probe into supply of ‘substandard’ materials at GB Pant Hospital

New Delhi: Chief Minister Arvind Kejriwal on Tuesday directed Health Minister Satyendar Jain to initiate a “thorough probe” into the supply of “substandard” materials, including surgical gloves and syringes, at the Delhi government-run GB Pant Hospital, and take strong action against the supplier and guilty officials. In a written communication to Jain, the chief minister sought a report on the action taken in the matter by September 20.

“The health minister should order a thorough probe into this whole incident, fix responsibility and take strong action against the supplier and guilty officials. Remedial measures should be taken at the earliest. All possible steps should be undertaken to ensure that all consumable and non-consumable supplies in all government hospitals meet defined quality standards,” Kejriwal said.

“Receipt of torn gloves and broken syringes is result of lack of effective quality control and supervision on the part of the authorities concerned,” he said.

It has been “clearly established” that the disposable sterile surgical gloves were supplied in “torn” condition, Kejriwal said, citing a report of the medical director of GB Pant Hospital.

The report was “silent” on the quality of syringes, he added.

  • Related Posts

    Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

    Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

    WHO Advises Against Antibiotics for COVID-19 Without Bacterial Infection

    Geneva, August 7, 2025 — The World Health Organization (WHO) has issued strong updated clinical recommendations: do not prescribe antibiotics to COVID-19 patients — whether severe or mild — unless…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India